GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phibro Animal Health Corp (NAS:PAHC) » Definitions » Piotroski F-Score

PAHC (Phibro Animal Health) Piotroski F-Score : 6 (As of Jul. 23, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Phibro Animal Health Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Phibro Animal Health has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Phibro Animal Health's Piotroski F-Score or its related term are showing as below:

PAHC' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 5   Max: 7
Current: 6

During the past 13 years, the highest Piotroski F-Score of Phibro Animal Health was 7. The lowest was 4. And the median was 5.


Phibro Animal Health Piotroski F-Score Historical Data

The historical data trend for Phibro Animal Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phibro Animal Health Piotroski F-Score Chart

Phibro Animal Health Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 6.00 4.00 6.00 5.00

Phibro Animal Health Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 5.00 5.00 7.00 6.00

Competitive Comparison of Phibro Animal Health's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phibro Animal Health's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Phibro Animal Health's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar25) TTM:Last Year (Mar24) TTM:
Net Income was 0.752 + 6.975 + 3.185 + 20.88 = $32 Mil.
Cash Flow from Operations was 28.429 + 12.622 + 3.076 + 43.154 = $87 Mil.
Revenue was 273.164 + 260.432 + 309.261 + 347.825 = $1,191 Mil.
Gross Profit was 87.15 + 83.495 + 101.87 + 104.568 = $377 Mil.
Average Total Assets from the begining of this year (Mar24)
to the end of this year (Mar25) was
(979.035 + 982.184 + 966.289 + 1285.509 + 1317.26) / 5 = $1106.0554 Mil.
Total Assets at the begining of this year (Mar24) was $979 Mil.
Long-Term Debt & Capital Lease Obligation was $745 Mil.
Total Current Assets was $776 Mil.
Total Current Liabilities was $266 Mil.
Net Income was 11.498 + -8.015 + 1.274 + 8.405 = $13 Mil.

Revenue was 255.049 + 231.349 + 249.943 + 263.223 = $1,000 Mil.
Gross Profit was 76.666 + 67.726 + 78.616 + 79.6 = $303 Mil.
Average Total Assets from the begining of last year (Mar23)
to the end of last year (Mar24) was
(965.432 + 971.397 + 964.523 + 972.708 + 979.035) / 5 = $970.619 Mil.
Total Assets at the begining of last year (Mar23) was $965 Mil.
Long-Term Debt & Capital Lease Obligation was $486 Mil.
Total Current Assets was $597 Mil.
Total Current Liabilities was $189 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Phibro Animal Health's current Net Income (TTM) was 32. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Phibro Animal Health's current Cash Flow from Operations (TTM) was 87. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar24)
=31.792/979.035
=0.03247279

ROA (Last Year)=Net Income/Total Assets (Mar23)
=13.162/965.432
=0.01363328

Phibro Animal Health's return on assets of this year was 0.03247279. Phibro Animal Health's return on assets of last year was 0.01363328. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Phibro Animal Health's current Net Income (TTM) was 32. Phibro Animal Health's current Cash Flow from Operations (TTM) was 87. ==> 87 > 32 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=744.783/1106.0554
=0.67336862

Gearing (Last Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=486.07/970.619
=0.50078352

Phibro Animal Health's gearing of this year was 0.67336862. Phibro Animal Health's gearing of last year was 0.50078352. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar25)=Total Current Assets/Total Current Liabilities
=776.018/266.481
=2.91209505

Current Ratio (Last Year: Mar24)=Total Current Assets/Total Current Liabilities
=597.18/189.072
=3.15847931

Phibro Animal Health's current ratio of this year was 2.91209505. Phibro Animal Health's current ratio of last year was 3.15847931. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Phibro Animal Health's number of shares in issue this year was 40.709. Phibro Animal Health's number of shares in issue last year was 40.52. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=377.083/1190.682
=0.31669497

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=302.608/999.564
=0.30273999

Phibro Animal Health's gross margin of this year was 0.31669497. Phibro Animal Health's gross margin of last year was 0.30273999. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar24)
=1190.682/979.035
=1.2161792

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar23)
=999.564/965.432
=1.03535412

Phibro Animal Health's asset turnover of this year was 1.2161792. Phibro Animal Health's asset turnover of last year was 1.03535412. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+0+0+1+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Phibro Animal Health has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Phibro Animal Health  (NAS:PAHC) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Phibro Animal Health Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Phibro Animal Health's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Phibro Animal Health Business Description

Traded in Other Exchanges
Address
300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Executives
E Thomas Corcoran director
Judith Weinstein officer: See Remarks C/O PHIBRO ANIMAL HEALTH CORP, 300 FRANK W. BURR BOULEVARD, STE 21, TEANECK NJ 07666
Alejandro Bernal director C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Larry Lee Miller officer: Chief Operating Officer 8 HAZELWOOD COURT, WARREN NJ 07059
Damian Finio officer: Chief Financial Officer C/O IGI LABORATORIES, INC., 105 LINCOLN AVENUE, BUENA NJ 08310
Robin Aukerman officer: President,North America Region C/O PHIBRO, GLENPOINTE CENTRE EAST, 3RD FL, 300 FRANK W. BURR BLVD, STE 21, TEANECK NJ 07666
Daniel M Bendheim director, officer: Exec. VP, Corporate Strategy 300 FRANK W. BURR BOULEVARD, SUITE 21, TEANECK NJ 07666
Dean J Warras officer: Pres Animal Health & Nutr N.A. 5113 SPYGLASS HILL, QUINCY IL 62305
Jack Bendheim director, 10 percent owner, officer: President and CEO C/O EMPIRE RESOURCES, INC., 1 PARKER PLAZA, SUIET 10, FORT LEE NJ 07024
Bfi Co., Llc 10 percent owner 300 FRANK W. BURR BLVD., STE 21, TEANECK NJ 07666
Jonathan Bendheim director GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ 07666
Anthony Andolino officer: SEE REMARKS GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., STE 21, TEANECK NJ 07666
Richard G Johnson officer: Chief Financial Officer 7 WEST 96TH STREET, APT. 11C, NEW YORK NY 10025
Gerald K Carlson director 2496 OLD BEACH ROAD, WAYZATA MN 55391
Thomas G Dagger officer: SVP, Gen Counsel and Corp Sec 41 WILCOX DRIVE, MOUNTAIN LAKES NJ 07046